These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

756 related articles for article (PubMed ID: 19191632)

  • 21. A health systems assessment of the KwaZulu-Natal tuberculosis programme in the context of increasing drug resistance.
    Loveday M; Thomson L; Chopra M; Ndlela Z
    Int J Tuberc Lung Dis; 2008 Sep; 12(9):1042-7. PubMed ID: 18713502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surveillance of drug-resistant tuberculosis in the state of Gujarat, India.
    Ramachandran R; Nalini S; Chandrasekar V; Dave PV; Sanghvi AS; Wares F; Paramasivan CN; Narayanan PR; Sahu S; Parmar M; Chadha S; Dewan P; Chauhan LS
    Int J Tuberc Lung Dis; 2009 Sep; 13(9):1154-60. PubMed ID: 19723407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting human macrophages for enhanced killing of intracellular XDR-TB and MDR-TB.
    Martins M; Viveiros M; Couto I; Amaral L
    Int J Tuberc Lung Dis; 2009 May; 13(5):569-73. PubMed ID: 19383188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of extensively drug-resistant tuberculosis and role of the pharmacist.
    Mitrzyk BM
    Pharmacotherapy; 2008 Oct; 28(10):1243-54. PubMed ID: 18823220
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug resistance in tuberculosis and options available.
    Chugh S
    J Indian Med Assoc; 2010 Feb; 108(2):106-8. PubMed ID: 20839567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extensively drug-resistant tuberculosis is worse than multidrug-resistant tuberculosis: different methodology and settings, same results.
    Migliori GB; Lange C; Girardi E; Centis R; Besozzi G; Kliiman K; Ortmann J; Matteelli A; Spanevello A; Cirillo DM;
    Clin Infect Dis; 2008 Mar; 46(6):958-9. PubMed ID: 18288911
    [No Abstract]   [Full Text] [Related]  

  • 27. Multidrug-resistant and extensively drug-resistant tuberculosis: a review.
    Chan ED; Iseman MD
    Curr Opin Infect Dis; 2008 Dec; 21(6):587-95. PubMed ID: 18978526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MDR- and XDR-TB among suspected drug-resistant TB patients in a tertiary care hospital in India.
    James P; Gupta R; Christopher DJ; Thankagunam B; Veeraraghavan B
    Clin Respir J; 2011 Jan; 5(1):19-25. PubMed ID: 21159137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comment on: Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.
    Yew WW; Chang KC; Chau CH
    J Antimicrob Chemother; 2009 Nov; 64(5):1119; author reply 1119-20. PubMed ID: 19666903
    [No Abstract]   [Full Text] [Related]  

  • 30. Drug-resistant tuberculosis. In South Africa, XDR TB and HIV prove a deadly combination.
    Koenig R
    Science; 2008 Feb; 319(5865):894-7. PubMed ID: 18276863
    [No Abstract]   [Full Text] [Related]  

  • 31. Multidrug-resistant and extensively drug-resistant tuberculosis: The new face of an old disease.
    Ferguson LA; Rhoads J
    J Am Acad Nurse Pract; 2009 Nov; 21(11):603-9. PubMed ID: 19900222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis--authors' response.
    Koh WJ; Shim TS
    J Antimicrob Chemother; 2009 Nov; 64(5):1119-20. PubMed ID: 19744986
    [No Abstract]   [Full Text] [Related]  

  • 33. Management of drug-resistant TB with individualised DST--the way forward?
    Singhal T; Gupta N
    J Assoc Physicians India; 2014 Jul; 62(7):561-3. PubMed ID: 25672025
    [No Abstract]   [Full Text] [Related]  

  • 34. Phenotypic and genotypic analysis of multidrug-resistant tuberculosis in Ethiopia.
    Agonafir M; Lemma E; Wolde-Meskel D; Goshu S; Santhanam A; Girmachew F; Demissie D; Getahun M; Gebeyehu M; van Soolingen D
    Int J Tuberc Lung Dis; 2010 Oct; 14(10):1259-65. PubMed ID: 20843416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in treatment outcomes of multidrug-resistant tuberculosis.
    Kwak N; Kim HR; Yoo CG; Kim YW; Han SK; Yim JJ
    Int J Tuberc Lung Dis; 2015 May; 19(5):525-30. PubMed ID: 25868019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Laboratory-Based Surveillance of Extensively Drug-Resistant Tuberculosis in Eastern China.
    Huang Y; Wu Q; Xu S; Zhong J; Chen S; Xu J; Zhu L; He H; Wang X
    Microb Drug Resist; 2017 Mar; 23(2):236-240. PubMed ID: 27754791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multidrug-resistant and extensively drug-resistant tuberculosis: implications for the HIV epidemic and antiretroviral therapy rollout in South Africa.
    Andrews JR; Shah NS; Gandhi N; Moll T; Friedland G;
    J Infect Dis; 2007 Dec; 196 Suppl 3():S482-90. PubMed ID: 18181698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Limited Effect of Later-Generation Fluoroquinolones in the Treatment of Ofloxacin-Resistant and Moxifloxacin-Susceptible Multidrug-Resistant Tuberculosis.
    Lee H; Ahn S; Hwang NY; Jeon K; Kwon OJ; Huh HJ; Lee NY; Kim CK; Koh WJ
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Totally drug-resistant and extremely drug-resistant tuberculosis: the same disease?
    Migliori GB; Centis R; D'Ambrosio L; Spanevello A; Borroni E; Cirillo DM; Sotgiu G
    Clin Infect Dis; 2012 May; 54(9):1379-80. PubMed ID: 22492321
    [No Abstract]   [Full Text] [Related]  

  • 40. Extensively drug-resistant tuberculosis treatment outcome in Iran: a case series of seven patients.
    Masjedi MR; Tabarsi P; Baghaei P; Jalali S; Farnia P; Chitsaz E; Amiri M; Mansouri D; Velayati AA
    Int J Infect Dis; 2010 May; 14(5):e399-402. PubMed ID: 19818664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.